ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global H1 Receptor Antagonist Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-1J8732
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global H2 Receptor Antagonist Market Insights and Forecast to 2028
BUY CHAPTERS

Global H1 Receptor Antagonist Market Research Report 2025

Code: QYRE-Auto-1J8732
Report
May 2025
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Merck
TEVA
Bayer
Pfizer Inc
Leti
Novartis
Hypera Pharma
Woodward
Johnson and Johnson
Ethical Pharma
Gems Pharma
KPL Pharma
GlaxoSmithKline PLC
Ying-Yuan
Schering Plough

H1 Receptor Antagonist Market Size

The global market for H1 Receptor Antagonist was valued at US$ 39990 million in the year 2024 and is projected to reach a revised size of US$ 66740 million by 2031, growing at a CAGR of 7.7% during the forecast period.

H1 Receptor Antagonist Market

H1 Receptor Antagonist Market

H1 receptor antagonists (H1 receptor antagonists, referred to as H1RAS) prevent histamine from acting on target cells by reversibly competing for histamine receptor sites on cells, and play a role by blocking and antagonizing H1 receptors. Anti-allergic effect, in order to prevent a series of physiological reactions from happening.
North American market for H1 Receptor Antagonist is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for H1 Receptor Antagonist is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of H1 Receptor Antagonist include Teva, Bayer, Pfizer, LETI, Novartis, Hypera Pharma, Woodward, Merck, Johnson and Johnson, Ethical pharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for H1 Receptor Antagonist, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding H1 Receptor Antagonist.
The H1 Receptor Antagonist market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global H1 Receptor Antagonist market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the H1 Receptor Antagonist manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of H1 Receptor Antagonist Market Report

Report Metric Details
Report Name H1 Receptor Antagonist Market
Accounted market size in year US$ 39990 million
Forecasted market size in 2031 US$ 66740 million
CAGR 7.7%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • First Generation H1RAS
  • Second-generation H1RAS
  • Third-generation H1RAS
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Teva, Bayer, Pfizer, LETI, Novartis, Hypera Pharma, Woodward, Merck, Johnson and Johnson, Ethical pharma, Gems pharma, KPL Pharma, GlaxoSmithKline, Ying Yuan, Schering-Plough
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of H1 Receptor Antagonist manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of H1 Receptor Antagonist in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is H1 Receptor Antagonist Market growing?

Ans: The H1 Receptor Antagonist Market witnessing a CAGR of 7.7% during the forecast period 2025-2031.

What is the H1 Receptor Antagonist Market size in 2031?

Ans: The H1 Receptor Antagonist Market size in 2031 will be US$ 66740 million.

Who are the main players in the H1 Receptor Antagonist Market report?

Ans: The main players in the H1 Receptor Antagonist Market are Teva, Bayer, Pfizer, LETI, Novartis, Hypera Pharma, Woodward, Merck, Johnson and Johnson, Ethical pharma, Gems pharma, KPL Pharma, GlaxoSmithKline, Ying Yuan, Schering-Plough

What are the Application segmentation covered in the H1 Receptor Antagonist Market report?

Ans: The Applications covered in the H1 Receptor Antagonist Market report are Hospital, Retail Pharmacy, Other

What are the Type segmentation covered in the H1 Receptor Antagonist Market report?

Ans: The Types covered in the H1 Receptor Antagonist Market report are First Generation H1RAS, Second-generation H1RAS, Third-generation H1RAS

Recommended Reports

Allergy Treatments

Receptor Antagonists

Cardiopulmonary Drugs

1 H1 Receptor Antagonist Market Overview
1.1 Product Definition
1.2 H1 Receptor Antagonist by Type
1.2.1 Global H1 Receptor Antagonist Market Value Comparison by Type (2024 VS 2031)
1.2.2 First Generation H1RAS
1.2.3 Second-generation H1RAS
1.2.4 Third-generation H1RAS
1.3 H1 Receptor Antagonist by Application
1.3.1 Global H1 Receptor Antagonist Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Global H1 Receptor Antagonist Market Size Estimates and Forecasts
1.4.1 Global H1 Receptor Antagonist Revenue 2020-2031
1.4.2 Global H1 Receptor Antagonist Sales 2020-2031
1.4.3 Global H1 Receptor Antagonist Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 H1 Receptor Antagonist Market Competition by Manufacturers
2.1 Global H1 Receptor Antagonist Sales Market Share by Manufacturers (2020-2025)
2.2 Global H1 Receptor Antagonist Revenue Market Share by Manufacturers (2020-2025)
2.3 Global H1 Receptor Antagonist Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of H1 Receptor Antagonist, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of H1 Receptor Antagonist, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of H1 Receptor Antagonist, Product Type & Application
2.7 Global Key Manufacturers of H1 Receptor Antagonist, Date of Enter into This Industry
2.8 Global H1 Receptor Antagonist Market Competitive Situation and Trends
2.8.1 Global H1 Receptor Antagonist Market Concentration Rate
2.8.2 The Global 5 and 10 Largest H1 Receptor Antagonist Players Market Share by Revenue
2.8.3 Global H1 Receptor Antagonist Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global H1 Receptor Antagonist Market Scenario by Region
3.1 Global H1 Receptor Antagonist Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global H1 Receptor Antagonist Sales by Region: 2020-2031
3.2.1 Global H1 Receptor Antagonist Sales by Region: 2020-2025
3.2.2 Global H1 Receptor Antagonist Sales by Region: 2026-2031
3.3 Global H1 Receptor Antagonist Revenue by Region: 2020-2031
3.3.1 Global H1 Receptor Antagonist Revenue by Region: 2020-2025
3.3.2 Global H1 Receptor Antagonist Revenue by Region: 2026-2031
3.4 North America H1 Receptor Antagonist Market Facts & Figures by Country
3.4.1 North America H1 Receptor Antagonist Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America H1 Receptor Antagonist Sales by Country (2020-2031)
3.4.3 North America H1 Receptor Antagonist Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe H1 Receptor Antagonist Market Facts & Figures by Country
3.5.1 Europe H1 Receptor Antagonist Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe H1 Receptor Antagonist Sales by Country (2020-2031)
3.5.3 Europe H1 Receptor Antagonist Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific H1 Receptor Antagonist Market Facts & Figures by Region
3.6.1 Asia Pacific H1 Receptor Antagonist Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific H1 Receptor Antagonist Sales by Region (2020-2031)
3.6.3 Asia Pacific H1 Receptor Antagonist Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America H1 Receptor Antagonist Market Facts & Figures by Country
3.7.1 Latin America H1 Receptor Antagonist Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America H1 Receptor Antagonist Sales by Country (2020-2031)
3.7.3 Latin America H1 Receptor Antagonist Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa H1 Receptor Antagonist Market Facts & Figures by Country
3.8.1 Middle East and Africa H1 Receptor Antagonist Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa H1 Receptor Antagonist Sales by Country (2020-2031)
3.8.3 Middle East and Africa H1 Receptor Antagonist Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global H1 Receptor Antagonist Sales by Type (2020-2031)
4.1.1 Global H1 Receptor Antagonist Sales by Type (2020-2025)
4.1.2 Global H1 Receptor Antagonist Sales by Type (2026-2031)
4.1.3 Global H1 Receptor Antagonist Sales Market Share by Type (2020-2031)
4.2 Global H1 Receptor Antagonist Revenue by Type (2020-2031)
4.2.1 Global H1 Receptor Antagonist Revenue by Type (2020-2025)
4.2.2 Global H1 Receptor Antagonist Revenue by Type (2026-2031)
4.2.3 Global H1 Receptor Antagonist Revenue Market Share by Type (2020-2031)
4.3 Global H1 Receptor Antagonist Price by Type (2020-2031)
5 Segment by Application
5.1 Global H1 Receptor Antagonist Sales by Application (2020-2031)
5.1.1 Global H1 Receptor Antagonist Sales by Application (2020-2025)
5.1.2 Global H1 Receptor Antagonist Sales by Application (2026-2031)
5.1.3 Global H1 Receptor Antagonist Sales Market Share by Application (2020-2031)
5.2 Global H1 Receptor Antagonist Revenue by Application (2020-2031)
5.2.1 Global H1 Receptor Antagonist Revenue by Application (2020-2025)
5.2.2 Global H1 Receptor Antagonist Revenue by Application (2026-2031)
5.2.3 Global H1 Receptor Antagonist Revenue Market Share by Application (2020-2031)
5.3 Global H1 Receptor Antagonist Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Teva
6.1.1 Teva Company Information
6.1.2 Teva Description and Business Overview
6.1.3 Teva H1 Receptor Antagonist Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Teva H1 Receptor Antagonist Product Portfolio
6.1.5 Teva Recent Developments/Updates
6.2 Bayer
6.2.1 Bayer Company Information
6.2.2 Bayer Description and Business Overview
6.2.3 Bayer H1 Receptor Antagonist Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Bayer H1 Receptor Antagonist Product Portfolio
6.2.5 Bayer Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Company Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer H1 Receptor Antagonist Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Pfizer H1 Receptor Antagonist Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 LETI
6.4.1 LETI Company Information
6.4.2 LETI Description and Business Overview
6.4.3 LETI H1 Receptor Antagonist Sales, Revenue and Gross Margin (2020-2025)
6.4.4 LETI H1 Receptor Antagonist Product Portfolio
6.4.5 LETI Recent Developments/Updates
6.5 Novartis
6.5.1 Novartis Company Information
6.5.2 Novartis Description and Business Overview
6.5.3 Novartis H1 Receptor Antagonist Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Novartis H1 Receptor Antagonist Product Portfolio
6.5.5 Novartis Recent Developments/Updates
6.6 Hypera Pharma
6.6.1 Hypera Pharma Company Information
6.6.2 Hypera Pharma Description and Business Overview
6.6.3 Hypera Pharma H1 Receptor Antagonist Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Hypera Pharma H1 Receptor Antagonist Product Portfolio
6.6.5 Hypera Pharma Recent Developments/Updates
6.7 Woodward
6.7.1 Woodward Company Information
6.7.2 Woodward Description and Business Overview
6.7.3 Woodward H1 Receptor Antagonist Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Woodward H1 Receptor Antagonist Product Portfolio
6.7.5 Woodward Recent Developments/Updates
6.8 Merck
6.8.1 Merck Company Information
6.8.2 Merck Description and Business Overview
6.8.3 Merck H1 Receptor Antagonist Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Merck H1 Receptor Antagonist Product Portfolio
6.8.5 Merck Recent Developments/Updates
6.9 Johnson and Johnson
6.9.1 Johnson and Johnson Company Information
6.9.2 Johnson and Johnson Description and Business Overview
6.9.3 Johnson and Johnson H1 Receptor Antagonist Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Johnson and Johnson H1 Receptor Antagonist Product Portfolio
6.9.5 Johnson and Johnson Recent Developments/Updates
6.10 Ethical pharma
6.10.1 Ethical pharma Company Information
6.10.2 Ethical pharma Description and Business Overview
6.10.3 Ethical pharma H1 Receptor Antagonist Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Ethical pharma H1 Receptor Antagonist Product Portfolio
6.10.5 Ethical pharma Recent Developments/Updates
6.11 Gems pharma
6.11.1 Gems pharma Company Information
6.11.2 Gems pharma Description and Business Overview
6.11.3 Gems pharma H1 Receptor Antagonist Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Gems pharma H1 Receptor Antagonist Product Portfolio
6.11.5 Gems pharma Recent Developments/Updates
6.12 KPL Pharma
6.12.1 KPL Pharma Company Information
6.12.2 KPL Pharma Description and Business Overview
6.12.3 KPL Pharma H1 Receptor Antagonist Sales, Revenue and Gross Margin (2020-2025)
6.12.4 KPL Pharma H1 Receptor Antagonist Product Portfolio
6.12.5 KPL Pharma Recent Developments/Updates
6.13 GlaxoSmithKline
6.13.1 GlaxoSmithKline Company Information
6.13.2 GlaxoSmithKline Description and Business Overview
6.13.3 GlaxoSmithKline H1 Receptor Antagonist Sales, Revenue and Gross Margin (2020-2025)
6.13.4 GlaxoSmithKline H1 Receptor Antagonist Product Portfolio
6.13.5 GlaxoSmithKline Recent Developments/Updates
6.14 Ying Yuan
6.14.1 Ying Yuan Company Information
6.14.2 Ying Yuan Description and Business Overview
6.14.3 Ying Yuan H1 Receptor Antagonist Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Ying Yuan H1 Receptor Antagonist Product Portfolio
6.14.5 Ying Yuan Recent Developments/Updates
6.15 Schering-Plough
6.15.1 Schering-Plough Company Information
6.15.2 Schering-Plough Description and Business Overview
6.15.3 Schering-Plough H1 Receptor Antagonist Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Schering-Plough H1 Receptor Antagonist Product Portfolio
6.15.5 Schering-Plough Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 H1 Receptor Antagonist Industry Chain Analysis
7.2 H1 Receptor Antagonist Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 H1 Receptor Antagonist Production Mode & Process Analysis
7.4 H1 Receptor Antagonist Sales and Marketing
7.4.1 H1 Receptor Antagonist Sales Channels
7.4.2 H1 Receptor Antagonist Distributors
7.5 H1 Receptor Antagonist Customer Analysis
8 H1 Receptor Antagonist Market Dynamics
8.1 H1 Receptor Antagonist Industry Trends
8.2 H1 Receptor Antagonist Market Drivers
8.3 H1 Receptor Antagonist Market Challenges
8.4 H1 Receptor Antagonist Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Merck
TEVA
Bayer
Pfizer Inc
Leti
Novartis
Hypera Pharma
Woodward
Johnson and Johnson
Ethical Pharma
Gems Pharma
KPL Pharma
GlaxoSmithKline PLC
Ying-Yuan
Schering Plough
List of Tables
 Table 1. Global H1 Receptor Antagonist Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global H1 Receptor Antagonist Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global H1 Receptor Antagonist Market Competitive Situation by Manufacturers in 2024
 Table 4. Global H1 Receptor Antagonist Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global H1 Receptor Antagonist Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global H1 Receptor Antagonist Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global H1 Receptor Antagonist Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market H1 Receptor Antagonist Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of H1 Receptor Antagonist, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of H1 Receptor Antagonist, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of H1 Receptor Antagonist, Product Type & Application
 Table 12. Global Key Manufacturers of H1 Receptor Antagonist, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global H1 Receptor Antagonist by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in H1 Receptor Antagonist as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global H1 Receptor Antagonist Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global H1 Receptor Antagonist Sales by Region (2020-2025) & (K Units)
 Table 18. Global H1 Receptor Antagonist Sales Market Share by Region (2020-2025)
 Table 19. Global H1 Receptor Antagonist Sales by Region (2026-2031) & (K Units)
 Table 20. Global H1 Receptor Antagonist Sales Market Share by Region (2026-2031)
 Table 21. Global H1 Receptor Antagonist Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global H1 Receptor Antagonist Revenue Market Share by Region (2020-2025)
 Table 23. Global H1 Receptor Antagonist Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global H1 Receptor Antagonist Revenue Market Share by Region (2026-2031)
 Table 25. North America H1 Receptor Antagonist Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America H1 Receptor Antagonist Sales by Country (2020-2025) & (K Units)
 Table 27. North America H1 Receptor Antagonist Sales by Country (2026-2031) & (K Units)
 Table 28. North America H1 Receptor Antagonist Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America H1 Receptor Antagonist Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe H1 Receptor Antagonist Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe H1 Receptor Antagonist Sales by Country (2020-2025) & (K Units)
 Table 32. Europe H1 Receptor Antagonist Sales by Country (2026-2031) & (K Units)
 Table 33. Europe H1 Receptor Antagonist Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe H1 Receptor Antagonist Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific H1 Receptor Antagonist Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific H1 Receptor Antagonist Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific H1 Receptor Antagonist Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific H1 Receptor Antagonist Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific H1 Receptor Antagonist Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America H1 Receptor Antagonist Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America H1 Receptor Antagonist Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America H1 Receptor Antagonist Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America H1 Receptor Antagonist Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America H1 Receptor Antagonist Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa H1 Receptor Antagonist Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa H1 Receptor Antagonist Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa H1 Receptor Antagonist Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa H1 Receptor Antagonist Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa H1 Receptor Antagonist Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global H1 Receptor Antagonist Sales (K Units) by Type (2020-2025)
 Table 51. Global H1 Receptor Antagonist Sales (K Units) by Type (2026-2031)
 Table 52. Global H1 Receptor Antagonist Sales Market Share by Type (2020-2025)
 Table 53. Global H1 Receptor Antagonist Sales Market Share by Type (2026-2031)
 Table 54. Global H1 Receptor Antagonist Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global H1 Receptor Antagonist Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global H1 Receptor Antagonist Revenue Market Share by Type (2020-2025)
 Table 57. Global H1 Receptor Antagonist Revenue Market Share by Type (2026-2031)
 Table 58. Global H1 Receptor Antagonist Price (US$/Unit) by Type (2020-2025)
 Table 59. Global H1 Receptor Antagonist Price (US$/Unit) by Type (2026-2031)
 Table 60. Global H1 Receptor Antagonist Sales (K Units) by Application (2020-2025)
 Table 61. Global H1 Receptor Antagonist Sales (K Units) by Application (2026-2031)
 Table 62. Global H1 Receptor Antagonist Sales Market Share by Application (2020-2025)
 Table 63. Global H1 Receptor Antagonist Sales Market Share by Application (2026-2031)
 Table 64. Global H1 Receptor Antagonist Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global H1 Receptor Antagonist Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global H1 Receptor Antagonist Revenue Market Share by Application (2020-2025)
 Table 67. Global H1 Receptor Antagonist Revenue Market Share by Application (2026-2031)
 Table 68. Global H1 Receptor Antagonist Price (US$/Unit) by Application (2020-2025)
 Table 69. Global H1 Receptor Antagonist Price (US$/Unit) by Application (2026-2031)
 Table 70. Teva Company Information
 Table 71. Teva Description and Business Overview
 Table 72. Teva H1 Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Teva H1 Receptor Antagonist Product
 Table 74. Teva Recent Developments/Updates
 Table 75. Bayer Company Information
 Table 76. Bayer Description and Business Overview
 Table 77. Bayer H1 Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Bayer H1 Receptor Antagonist Product
 Table 79. Bayer Recent Developments/Updates
 Table 80. Pfizer Company Information
 Table 81. Pfizer Description and Business Overview
 Table 82. Pfizer H1 Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Pfizer H1 Receptor Antagonist Product
 Table 84. Pfizer Recent Developments/Updates
 Table 85. LETI Company Information
 Table 86. LETI Description and Business Overview
 Table 87. LETI H1 Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. LETI H1 Receptor Antagonist Product
 Table 89. LETI Recent Developments/Updates
 Table 90. Novartis Company Information
 Table 91. Novartis Description and Business Overview
 Table 92. Novartis H1 Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Novartis H1 Receptor Antagonist Product
 Table 94. Novartis Recent Developments/Updates
 Table 95. Hypera Pharma Company Information
 Table 96. Hypera Pharma Description and Business Overview
 Table 97. Hypera Pharma H1 Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Hypera Pharma H1 Receptor Antagonist Product
 Table 99. Hypera Pharma Recent Developments/Updates
 Table 100. Woodward Company Information
 Table 101. Woodward Description and Business Overview
 Table 102. Woodward H1 Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Woodward H1 Receptor Antagonist Product
 Table 104. Woodward Recent Developments/Updates
 Table 105. Merck Company Information
 Table 106. Merck Description and Business Overview
 Table 107. Merck H1 Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Merck H1 Receptor Antagonist Product
 Table 109. Merck Recent Developments/Updates
 Table 110. Johnson and Johnson Company Information
 Table 111. Johnson and Johnson Description and Business Overview
 Table 112. Johnson and Johnson H1 Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Johnson and Johnson H1 Receptor Antagonist Product
 Table 114. Johnson and Johnson Recent Developments/Updates
 Table 115. Ethical pharma Company Information
 Table 116. Ethical pharma Description and Business Overview
 Table 117. Ethical pharma H1 Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Ethical pharma H1 Receptor Antagonist Product
 Table 119. Ethical pharma Recent Developments/Updates
 Table 120. Gems pharma Company Information
 Table 121. Gems pharma Description and Business Overview
 Table 122. Gems pharma H1 Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Gems pharma H1 Receptor Antagonist Product
 Table 124. Gems pharma Recent Developments/Updates
 Table 125. KPL Pharma Company Information
 Table 126. KPL Pharma Description and Business Overview
 Table 127. KPL Pharma H1 Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. KPL Pharma H1 Receptor Antagonist Product
 Table 129. KPL Pharma Recent Developments/Updates
 Table 130. GlaxoSmithKline Company Information
 Table 131. GlaxoSmithKline Description and Business Overview
 Table 132. GlaxoSmithKline H1 Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. GlaxoSmithKline H1 Receptor Antagonist Product
 Table 134. GlaxoSmithKline Recent Developments/Updates
 Table 135. Ying Yuan Company Information
 Table 136. Ying Yuan Description and Business Overview
 Table 137. Ying Yuan H1 Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Ying Yuan H1 Receptor Antagonist Product
 Table 139. Ying Yuan Recent Developments/Updates
 Table 140. Schering-Plough Company Information
 Table 141. Schering-Plough Description and Business Overview
 Table 142. Schering-Plough H1 Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Schering-Plough H1 Receptor Antagonist Product
 Table 144. Schering-Plough Recent Developments/Updates
 Table 145. Key Raw Materials Lists
 Table 146. Raw Materials Key Suppliers Lists
 Table 147. H1 Receptor Antagonist Distributors List
 Table 148. H1 Receptor Antagonist Customers List
 Table 149. H1 Receptor Antagonist Market Trends
 Table 150. H1 Receptor Antagonist Market Drivers
 Table 151. H1 Receptor Antagonist Market Challenges
 Table 152. H1 Receptor Antagonist Market Restraints
 Table 153. Research Programs/Design for This Report
 Table 154. Key Data Information from Secondary Sources
 Table 155. Key Data Information from Primary Sources
 Table 156. Authors List of This Report


List of Figures
 Figure 1. Product Picture of H1 Receptor Antagonist
 Figure 2. Global H1 Receptor Antagonist Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global H1 Receptor Antagonist Market Share by Type: 2024 & 2031
 Figure 4. First Generation H1RAS Product Picture
 Figure 5. Second-generation H1RAS Product Picture
 Figure 6. Third-generation H1RAS Product Picture
 Figure 7. Global H1 Receptor Antagonist Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global H1 Receptor Antagonist Market Share by Application: 2024 & 2031
 Figure 9. Hospital
 Figure 10. Retail Pharmacy
 Figure 11. Other
 Figure 12. Global H1 Receptor Antagonist Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global H1 Receptor Antagonist Market Size (2020-2031) & (US$ Million)
 Figure 14. Global H1 Receptor Antagonist Sales (2020-2031) & (K Units)
 Figure 15. Global H1 Receptor Antagonist Average Price (US$/Unit) & (2020-2031)
 Figure 16. H1 Receptor Antagonist Report Years Considered
 Figure 17. H1 Receptor Antagonist Sales Share by Manufacturers in 2024
 Figure 18. Global H1 Receptor Antagonist Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest H1 Receptor Antagonist Players: Market Share by Revenue in H1 Receptor Antagonist in 2024
 Figure 20. H1 Receptor Antagonist Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global H1 Receptor Antagonist Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America H1 Receptor Antagonist Sales Market Share by Country (2020-2031)
 Figure 23. North America H1 Receptor Antagonist Revenue Market Share by Country (2020-2031)
 Figure 24. United States H1 Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada H1 Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe H1 Receptor Antagonist Sales Market Share by Country (2020-2031)
 Figure 27. Europe H1 Receptor Antagonist Revenue Market Share by Country (2020-2031)
 Figure 28. Germany H1 Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France H1 Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. H1 Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy H1 Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia H1 Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific H1 Receptor Antagonist Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific H1 Receptor Antagonist Revenue Market Share by Region (2020-2031)
 Figure 35. China H1 Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan H1 Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea H1 Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India H1 Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia H1 Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan H1 Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Southeast Asia H1 Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America H1 Receptor Antagonist Sales Market Share by Country (2020-2031)
 Figure 43. Latin America H1 Receptor Antagonist Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico H1 Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil H1 Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina H1 Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa H1 Receptor Antagonist Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa H1 Receptor Antagonist Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey H1 Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia H1 Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE H1 Receptor Antagonist Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of H1 Receptor Antagonist by Type (2020-2031)
 Figure 53. Global Revenue Market Share of H1 Receptor Antagonist by Type (2020-2031)
 Figure 54. Global H1 Receptor Antagonist Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of H1 Receptor Antagonist by Application (2020-2031)
 Figure 56. Global Revenue Market Share of H1 Receptor Antagonist by Application (2020-2031)
 Figure 57. Global H1 Receptor Antagonist Price (US$/Unit) by Application (2020-2031)
 Figure 58. H1 Receptor Antagonist Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Global Alpha receptor Antagonists Market Research Report 2024
Global H2 Receptor Antagonists Market Insights Forecast to 2030
Global H2 Receptor Blocker Market Research Report 2025
Anti Hypertensive Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Antihypertensive Agents Market Research Report 2024
Global Antihistamines Market Research Report 2024
Global Ant Killer Market Research Report 2024
Global Diagnostic Guidewire Market Research Report 2024
Global Pulmonary Hypertension Drug Market Research Report 2025
Global Hypertensive Heart Disease Drug Market Research Report 2025
Global Pill Organizer with Timer Reminder Market Research Report 2025
Global Proton Pump Inhibitor Drug Market Research Report 2025
Opioid Antagonist Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Immune Drugs Market Insights Forecast to 2030
Influenza Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Weekly Pill Organizer Market Research Report 2025
Global Still s Disease Treatment Market Research Report 2025
Global 5HT3 Receptor Antagonists Market Research Report 2025
Global Aquaculture Bacterial Diagnosis Market Research Report 2025
Medication for Portal Hypertension Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions